Immix Biopharma's total assets for Q1 2025 were $19.89M, a decrease of -13.32% from the previous quarter. IMMX total liabilities were $10.30M for the fiscal quarter, a 6.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.